In summary, neuroendocrine lineage transcription patterns are highly predictive of prognosis in neuroblastoma, and YAP‐1 evaluation may contribute to a more accurate characterization of recurrence risk in neuroblastoma patients.42 Here, YAP1 is linked to neuroblastoma.